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Background: evidence is limited regarding risk and the shape of the 
exposure–response curve at low asbestos exposure levels. We esti-
mated the exposure–response for occupational asbestos exposure and 
assessed the joint effect of asbestos exposure and smoking by sex and 
lung cancer subtype in general population studies.
Methods: We pooled 14 case–control studies conducted in 1985–
2010 in europe and canada, including 17,705 lung cancer cases and 
21,813 controls with detailed information on tobacco habits and life-
time occupations. We developed a quantitative job-exposure-matrix 
to estimate job-, time period-, and region-specific exposure levels. 
Fiber-years (ff/ml-years) were calculated for each subject by link-
ing the matrix with individual occupational histories. We fit uncondi-
tional logistic regression models to estimate odds ratios (Ors), 95% 
confidence intervals (cis), and trends.
Results: the fully adjusted Or for ever-exposure to asbestos was 
1.24 (95% ci, 1.18, 1.31) in men and 1.12 (95% ci, 0.95, 1.31) 
in women. in men, increasing lung cancer risk was observed with 
increasing exposure in all smoking categories and for all three major 
lung cancer subtypes. in women, lung cancer risk for all subtypes 
was increased in current smokers (Ors ~two-fold). the joint effect 
of asbestos exposure and smoking did not deviate from multiplicativ-
ity among men, and was more than additive among women.
Conclusions: Our results in men showed an excess risk of lung cancer 
and its subtypes at low cumulative exposure levels, with a steeper expo-
sure–response slope in this exposure range than at higher, previously 
studied levels. (See video abstract at, http://links.lww.com/eDe/B161.)
(Epidemiology 2017;28: 288–299)
Asbestos is a general term for a group of mineral silicate fibers naturally found on all continents; the commercial-
ized types are the serpentine mineral chrysotile (white asbes-
tos) and the amphibole minerals amosite (brown asbestos), 
anthophyllite, crocidolite (blue asbestos), and tremolite.1 
asbestos fibers are generally considered strong, flexible, 
stable, heat-resistant, and durable; they have therefore been 
attractive for a wide range of industrial applications for over a 
century. consequently, large groups of workers have been (and 
still are, in many countries) exposed to asbestos, for exam-
ple in the insulation, textile, cement, roofing, and refractory 
industries. the highest exposure levels have been measured 
among workers manufacturing asbestos products or employed 
in asbestos mining and milling operations.2 asbestos has been 
banned successively since 1980s in many countries due to its 
adverse health effects.3 nevertheless, exposure may still occur 
when buildings insulated with asbestos are demolished, when 
asbestos is removed from any type of structure, and during 
maintenance and repair of asbestos-containing materials.2 the 
World Health Organization (WHO) estimated in 2006 that 125 
million workers worldwide are still exposed to asbestos.4
the international agency for research on cancer 
(iarc) Monographs Programme evaluated the carcinogenic-
ity of asbestos in 1973, 1977, 1987, and 2011; the Working 
group concluded in the most recent evaluation (Vol. 100c) 
that all forms of asbestos cause mesothelioma and cancer of 
the lung, larynx, and ovary,3 and made no distinction by lung 
cancer cell type when evaluating asbestos carcinogenicity to 
the lung.
lung cancer is the most common cancer globally.5 
tobacco smoking is well established as the main cause; for 
instance, in the United Kingdom, an estimated 85% of lung 
cancers in men and 47% of lung cancers in women are attrib-
utable to tobacco smoking.6 asbestos is the most important 
occupational carcinogen, and lung cancer is the most common 
asbestos-related cancer.7
asbestos was the first occupational exposure to be sug-
gested to have a joint effect with smoking.8 Several studies 
and reviews have supported this hypothesis, but the type of 
interaction (additive or multiplicative) has been debated.9–13
Here, we used a pooled dataset of lung cancer case–con-
trol studies conducted in europe and canada (the SYnergY 
project) to estimate lung cancer risk related to occupational 
asbestos exposure, and its interaction with smoking. the 
objectives of this work were to (1) estimate the lung cancer risk 
associated with quantitative indices of occupational asbestos 
exposure by sex, while adjusting for smoking; (2) assess the 
exposure–response relationship for asbestos and lung cancer 
by sex, major subtype, and smoking status; and (3) assess the 
joint effect of asbestos exposure and smoking on an additive 
and multiplicative scale.
METHODS
The SYNERGY Project
Fourteen case–control studies on lung cancer from 
europe and canada (see etable 1 at http://links.lww.com/
eDe/B144) were pooled in the SYnergY project to study 
joint effects of occupational carcinogens, including asbes-
tos, and smoking in relation to lung cancer risk. the studies 
lUca and lUcaS were restricted to men, and PariS to 
regular smokers with squamous-cell lung carcinoma (SQlc) 
and small-cell lung carcinoma (Sclc). Participation rates 
were 62%–98% (mean, 83%) among cases and 41%–100% 
(mean, 70%) among controls. all studies collected lifetime 
smoking histories and complete occupational histories, except 
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MOrgen. MOrgen is a case–control study nested in the 
european Prospective investigation into cancer and nutrition 
(ePic) study in the netherlands, where 45% of those invited 
completed a questionnaire at recruitment.
the data were collected in 1985–2010, and almost all 
interviews with study participants were conducted face-to-
face. lUcaS and MOrgen collected data using self-admin-
istered questionnaires, and women in MOntreal and some 
participants in tOrOntO were interviewed by phone. next-
of-kin were interviewed for most cases and some controls in 
lUcaS and some participants in icare and MOntreal 
(9% of cases, 6% of controls). controls were individually 
or frequency-matched to cases by sex and age, and mainly 
recruited from the general population (79%). lung cancer 
subtypes were classified according to WHO guidelines after 
histological or cytological confirmation. reference pathology 
was performed for the german cases.14 ethical approvals for 
the original studies were obtained in accordance with legisla-
tion in each country, and in addition from the iarc ethics 
committee. More information about the SYnergY project 
is available at: http://synergy.iarc.fr.
Occupational data consisted of a list of employment 
periods for every study subject. For every period, job and 
industrial activity had been recorded, coded respectively to 
the international Standard classification of Occupations from 
1968 (iScO-68) and the international Standard classification 
of industries, revision 2, along with the start and end years.
Assessment of Occupational Asbestos Exposure
Quantitative measurements of fibers (71,816) from 14 
countries (mainly germany, the UK, canada, italy, France, 
and norway) were entered into the project-specific exposure 
database expoSYn according to a standardized protocol.15 
Most data points were determined by phase-contrast micros-
copy (>95%). it can be assumed that most data represented 
chrysotile (67%). regarding measurement strategies, 53% 
of the measurements were considered “representative,” 9% 
“worst case,” and 38% “unknown.”15 all measurements were 
linked to a standardized (iScO-68) job title. Statistical mod-
els were applied to the personal measurements (27,958) col-
lected in 1971–2009 to develop a project-specific quantitative 
job-exposure-matrix (SYn-JeM) for occupational asbestos 
exposure. Some measurements were attributed to jobs clearly 
unrelated to asbestos exposure, like teachers; we assumed 
these to represent exceptional situations, which should not be 
generalized to all individuals in that job. therefore, a semi-
quantitative general population job-exposure matrix based on 
iScO-68 codes (DOM-JeM) was used in the model, where 
every job was rated as nonexposed (=0), low exposed with 
regard to exposure intensity or high exposed with low expo-
sure probability (=1), or high exposed with high-exposure 
probability (=2). Jobs considered to be nonexposed in DOM-
JeM were set to 0 fibers per milliliter (ff/ml) in SYn-JeM, 
disregarding actual measurements, if any. When there were <5 
measurements for a specific job, the geometric mean estimate 
of all jobs within the same unit or major group was applied, so 
the job estimate was based on information from the most simi-
lar jobs. Because every job was expert-rated as being non-, 
low-, or high exposed, an exposure level for every potential 
job could be calculated, even in the absence of measurements 
for that particular job. additional SYn-JeM model specifi-
cations and sensitivity analyses using alternative models are 
described elsewhere.16–18 in brief, for all countries and occu-
pations together, we implemented a linear historical trend with 
an annual decrease of fiber concentrations of −10.7% before 
ban implementation and no further downward trend after ban 
implementation, and an exposure ceiling before 1975 to avoid 
unrealistically high estimates due to unrestrained back-extrap-
olation to periods when actual measurements were not carried 
out. linking the occupational histories of the participants to 
SYn-JeM generated individual job-, region-, and year-spe-
cific estimates of the average intensity of asbestos exposure 
during a standard 8-hour working day in ff/ml. cumulative 
asbestos exposure (expressed as ff/ml-years) was defined as 
the average exposure intensity in a particular job multiplied 
by the years of employment, and totaled over the working life 
of the participants.
Statistical Analyses
Unconditional logistic regression models were fitted 
to generate odds ratios (Ors) and 95% confidence intervals 
(cis) of lung cancer associated with various indices of asbes-
tos exposure. the subjects classified as nonexposed were the 
reference category in each of the analyses.
three strategies for adjustment were applied: the first 
model (Or1) adjusted for age group (<45, 45–49, 50–54, 
55–59, 60–64, 65–69, 70–74, 75+ years) and study; the sec-
ond model (Or2) also adjusted for tobacco smoking as a 
continuous variable (log[cigarette pack-years + 1]) and for 
time-since-quitting smoking cigarettes (current smokers; quit-
ting 2–7, 8–15, 16–25, 26+ years before diagnosis/interview; 
never-smokers); and the third model (Or3) also adjusted for 
ever-employment in a “list a” job (yes/no). “list a” is a list 
of occupations and industries known to present an excess 
risk of lung cancer, compiled by ahrens and Merletti19 and 
updated by Mirabelli et al.20 Here, we modified “list a” so that 
jobs originally included solely because of asbestos exposure 
were excluded, to avoid potential over-adjustment. examples 
are asbestos cement product makers, insulators, some jobs in 
mining and quarrying, and some jobs in manufacture of non-
metallic mineral products not elsewhere classified (e.g., other 
crushers, grinders, and mixers; beam warpers; loom threaders; 
fabric examiners and repairers; spinners and winders).
current smokers were people who had smoked >1 ciga-
rette per day for >1 year, including those who had stopped 
smoking in the 2 years before diagnosis/interview. cigarette 
pack-years were calculated as: ∑duration × average intensity 
per day/20.
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We used kernel plots to describe the distribution of 
cumulative asbestos exposure among cases and controls. 
cumulative asbestos exposure in ff/ml-years was categorized 
according to quartiles of its distribution in controls for the 
main exposure–response analyses. in the analyses stratified by 
lung cancer subtype and smoking status, we used two expo-
sure categories (below and above the median) because the 
number of observations was limited.
P values for linear trend were obtained by applying a 
logistic regression model including the respective continu-
ous variable. the trend was calculated among all subjects and 
among exposed subjects only.
We examined robustness of results by sensitivity analy-
ses as follows:
1. excluding one study at a time, to see if any specific study 
largely influenced the overall result;
2. excluding one industry at a time, to see if any specific 
industry largely influenced the overall result;
3. stratification by hospital- and population-based studies, to 
assess if associations differed by study design;
4. restricting the study base to blue-collar workers, to limit 
potential residual confounding from socioeconomic factors;
5. restricting the analyses to workers who started working in 
1960 or later, as exposure data were scarce before the 1960s 
and exposure estimates in SYn-JeM may be affected by 
larger uncertainty;
6. excluding “laborers not elsewhere classified” (iScO 
9–99.10) because they represent a substantial proportion 
of exposed workers in some of the studies, to see if their 
inclusion had unduly influenced the results.
a multinomial logistic regression model and a likeli-
hood ratio test were used to explore heterogeneity between the 
three major lung cancer subtypes in relation to a categorical 
variable of cumulative asbestos exposure.
lagging of cumulative exposure was applied, in which 
exposure in the 5, 10, 15, or 20 years before diagnosis/inter-
view was disregarded. as results did not differ by lag-times, 
we used unlagged models in the main analyses.
the slope of the exposure–response relationship reflects 
the average excess relative risk per fiber-year. it was obtained 
from a linear Or model adjusted for study, “list a” occupa-
tions, time-since-quitting smoking cigarettes, and smoking 
pack-year categories using maximum likelihood estimation 
and was expressed as KL * 100, that is, 100 times the excess 
relative risk per fiber-year.
We performed additional spline analyses using non-
parametric smoothing as implemented in the r package mgcv 
to assess in more detail the shape of the exposure–response 
relationship. the optimal smoothing parameter was selected 
based on generalized cross-validation and under the assump-
tion that the total degrees of freedom required for a biologi-
cally plausible model would not exceed 3. 95% cis for Ors 
were derived by simulation from the posterior distribution 
of the model coefficients, performing random draws from a 
multivariate normal distribution parameterized by the esti-
mated mean vector and estimated covariance matrix of the 
model coefficients.
Meta-analyses were conducted to explore study-specific 
Ors using the Stata command “metan,” where the extent of 
heterogeneity between Or estimates was assessed as a per-
centage (I2).21
We assessed the additive interaction between smok-
ing and asbestos by estimating the relative excess risk due to 
interaction.22 We again used a linear Or model adjusted for 
covariates, and bootstrapped cis for the excess risk due to 
interaction. Departure from multiplicative interaction between 
smoking and asbestos was assessed by testing the asbestos–
smoking interaction term in the logistic model.
We conducted statistical analyses using SaS, version 
9.3 (SaS institute, cary, nc); Stata, version 12.1 (Stata-
corp, college Station, tX); and r, version 3.2.
RESULTS
We omitted study participants with incomplete data on 
covariates (804 cases, 848 controls), leaving 16,901 lung can-
cer cases (4,752 lung adenocarcinoma, 6,503 squamous cell 
carcinoma, 2,730 small-cell carcinoma, 2,822 other/unspeci-
fied lung cancer cell types, 94 not available) and 20,965 con-
trols for the analyses.
Characteristics of Subjects by Exposure Status
table 1 shows characteristics of study participants by 
asbestos exposure status, disease status, and sex. Smoking 
status differed by asbestos exposure status; nonexposed were 
more often never-smokers among both men and women. lung 
cancer pathology also differed by asbestos exposure status; 
adenocarcinoma was less frequent and squamous-cell carci-
noma more frequent among asbestos-exposed compared with 
nonexposed men and women. More cases with asbestos expo-
sure ever worked in other occupations with an anticipated lung 
cancer risk (20% in men) than controls (15% in men) or non-
exposed cases (5% in men).
Asbestos Exposure
at some time, 44% of cases (51% in men, 15% in women) 
and 35% of controls (41% in men, 11% in women) had been 
exposed to asbestos at their workplace. the exposure prevalence 
among male blue-collar workers was 63% in cases and 58% in 
controls. etable 1 (http://links.lww.com/eDe/B144) displays 
the period for which asbestos exposure was assigned to workers 
in different studies; it does not reflect when asbestos was banned 
as some jobs continued to be exposed after the ban. Prevalence 
of asbestos exposure among control subjects by study and sex, 
omitting “laborers not elsewhere classified” and restricting to 
DOM-JeM high levels of asbestos exposure, is displayed in the 
etables 2 and 3 (http://links.lww.com/eDe/B144).
Figure 1 shows the distribution of fiber-years in exposed 
control subjects by sex. Overall, women were exposed to 
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TABLE 1. Descriptive Characteristics of the Study Participants (16,901 Lung Cancer Cases, 20,965 Control Subjects) by 
Asbestos Exposure Status
 
 
Characteristic Exposure Category
Asbestos Exposed Nonexposed to Asbestos
Cases Controls Cases Controls
No.
% or  
Mean (SD) No.
% or  
Mean (SD) No.
% or  
Mean (SD) No.
% or  
Mean (SD)
Men
  age Mean (SD) 6,958 61.8 (9.0) 6,802 61.5 (9.3) 6,647 62.9 (8.9) 9,649 62.1 (9.5)
  age categorized (years) <45 269 3.9 367 5.4 217 3.3 528 5.5
45–64 3,728 53.6 3,514 51.7 3,257 49.0 4,668 48.4
65+ 2,961 42.6 2,921 42.9 3,173 47.7 4,453 46.1
  Smoking status never-smoker 205 2.9 1,546 22.7 285 4.3 2,891 30.0
Former smoker 2,422 34.8 3,135 46.1 2,365 35.6 4,193 43.5
current smoker 4,331 62.2 2,121 31.2 3,997 60.1 2,565 26.6
  Smoking pack-years 
(current and former 
smokers)
<10 296 4.4 1,001 19.0 312 4.9 1,465 21.7
10–19 647 9.6 1,024 19.5 568 8.9 1,399 20.7
20+ 5,810 86.0 3,231 61.5 5,482 86.2 3,894 57.6
  Years-since-quitting 
smoking (former smokers)
2–7 905 37.4 510 16.3 841 35.6 708 16.9
8–15 698 28.8 760 24.2 657 27.8 931 22.2
16–25 505 20.9 884 28.2 539 22.8 1,211 28.9
26+ 314 13.0 981 31.3 328 13.9 1,343 32.0
  employed in “list a” job ever 1,380 19.8 1,020 15.0 349 5.3 304 3.2
  lung cancer cell type not available 38 0.5 -  41 0.6 -  
adenocarcinoma 1,577 22.7 -  1,748 26.3 -  
Squamous-cell carcinoma 3,145 45.2 -  2,683 40.4 -  
Small-cell carcinoma 1,129 16.2 -  1,071 16.1 -  
Other/unspecified 1,069 15.4 -  1,104 16.6 -  
Women
  age Mean (SD) 482 60.6 (10.5) 510 61.9 (10.0) 2,814 60.4 (10.1) 4,004 59.7 (11.5)
  age categorized (years) <45 32 6.6 30 5.9 197 7.0 446 11.1
45–64 260 54.0 252 49.4 1,518 53.9 1,920 48.0
65+ 190 39.4 228 44.7 1,099 39.1 1,638 40.9
Smoking status never-smoker 101 21.0 267 52.4 778 27.6 2,449 61.2
Former smoker 75 15.6 126 24.7 570 20.3 766 19.1
current smoker 306 63.5 117 22.9 1,466 52.1 789 19.7
Smoking pack-years (current 
and former smokers)
<10 21 5.5 80 32.8 205 10.1 569 36.6
10–19 64 16.8 43 17.6 328 16.1 377 24.3
20–29 296 77.7 127 52.3 1,533 75.3 629 40.5
Years-since-quitting smoking 
(former smokers)
2–7 36 48.0 28 22.2 244 42.8 176 23.0
8–15 16 21.3 28 22.2 160 28.1 179 23.4
16–25 16 21.3 34 27.0 111 19.5 217 28.3
26+ 7 9.3 36 28.6 55 9.6 194 25.3
employed in “list a” job ever 32 6.6 22 4.3 26 1.0 18 0.5
lung cancer cell type not available 4 0.8 -  11 0.4 -  
adenocarcinoma 178 36.9 -  1,249 44.4 -  
Squamous-cell carcinoma 117 24.3 -  558 19.8 -  
Small-cell carcinoma 94 19.5 -  436 15.5 -  
Other/unspecified 89 18.5 -  560 19.9 -  
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lower cumulative levels (median, 0.57 ff/ml-years) than men 
(median, 1.21 ff/ml-years).
Lung Cancer Risk Associated with Asbestos 
Exposure
the Ors for lung cancer associated with ever occupa-
tional asbestos exposure changed after adjustment for smoking 
and for other occupational exposures. in men, Or1, from the 
model adjusted for age group and study, was 1.43 (95% ci, 1.37, 
1.50); Or2, also adjusted for smoking, was 1.29 (95% ci, 1.22, 
1.36); and Or3, also adjusted for ever-employment in a “list a” 
job, was 1.24 (95% ci, 1.18, 1.31). among women, Or1 was 
1.37 (95% ci, 1.19, 1.58), Or2 was 1.13 (95% ci, 0.97, 1.33), 
and Or3 was 1.12 (95% ci, 0.95, 1.31). in table 2 and all subse-
quent analyses, we present Or3 unless otherwise stated.
in men, Ors across most exposure categories by duration 
and cumulative exposure were increased compared with the ref-
erence category of never-exposed to asbestos (table 2). Only 
the first quartile of cumulative dose (<0.5 ff/ml-years) showed 
no increased risk (Or, 1.06; 95% ci, 0.96, 1.16). “time since 
last exposure” was also adjusted for duration and showed Ors 
between 1.10 and 1.19, with no time trend (P = 0.44).
in women, based on smaller numbers of exposed sub-
jects and a lower median exposure level, no increased Ors 
were observed (table 2).
nonparametric exposure–response analyses showed 
marginal support for a nonlinear exposure–response associa-
tion among men, which was larger for models with longer lag-
times, while the exposure–response was linear among women 
(Figure 2).
Study-specific results showed no heterogeneity between 
studies, with I2 = 0% in both men and women (eFigures 4 and 
5; http://links.lww.com/eDe/B144, which show forest plots 
and heterogeneity tests).
the exposure–response slope (KL * 100) among all men 
was 6.1 (95% ci, 4.1, 8.1) and among only blue-collar work-
ers was 3.3 (95% ci, 1.5, 5.0).
Sensitivity Analyses
the Or for ever-exposure to asbestos in men remained 
stable when omitting one study at a time; the highest Or, 1.27 
(95% ci, 1.19, 1.34), was observed when lUcaS was omit-
ted, and the lowest Or, 1.21 (95% ci, 1.14, 1.29), when aUt-
Munich was omitted (data not shown).
When excluding one industry or occupation at a time, 
the lung cancer risk in the highest quartile of cumulative expo-
sure in men (>2.8 ff/ml-years; Or, 1.38; 95% ci, 1.27, 1.50) 
remained elevated, as follows: excluding asbestos manufac-
turing (Or, 1.44; 95% ci, 1.32, 1.57), excluding construction 
(Or, 1.41; 95% ci, 1.27, 1.57), excluding mining (Or, 1.36; 
95% ci, 1.25, 1.49), excluding metal work (Or, 1.43; 95% 
ci, 1.31, 1.56), excluding transportation (Or, 1.42; 95% ci, 
1.30, 1.56), or excluding vehicle mechanic (Or, 1.46; 95% 
ci, 1.34, 1.60) (data not shown).
Further sensitivity analyses in men (table 3) on cumula-
tive asbestos exposure showed that stratifying the analyses by 
studies with population- and hospital-based controls made a 
difference; Ors in studies with hospital-based controls were 
generally lower and more imprecise. restricting the study 
population to blue-collar workers resulted in a systematic 
attenuation of the Or by about 10%–15%, although the sig-
nificant exposure–response trend persisted. restricting the 
study population to workers who started working after 1960 
also lowered the Ors, whereas excluding “laborers not else-
where classified” (iScO 9–99.10) did not markedly influence 
the overall results.
Lung Cancer Risk Associated with Cumulative 
Asbestos Exposure, Stratified by Major 
Histological Subtype and Smoking Status
table 4 shows Ors associated with cumulative asbestos 
exposure by major lung cancer subtype and by smoking status. 
Occupational asbestos exposure in men was associated with 
an increased lung cancer risk among never-smokers, former 
smokers, and current smokers. never-smokers with exposure 
above the median (>1.2 ff/ml-years) had slightly higher Ors 
than former or current smokers, particularly for small-cell car-
cinoma (Or, 2.73; 95% ci, 1.39, 5.35). Ors were higher for 
squamous and small-cell carcinoma than for lung adenocar-
cinoma (P = 0.11 for the likelihood ratio test of homogene-
ity from the multinomial logistic regression model when these 
three subtypes were included). in women, stratifying by smok-
ing status and lung cancer subtype revealed associations in sub-
groups. among current smokers, we observed associations of 
asbestos exposure with all lung cancer subtypes, with all Ors 
increased approximately two-fold. in former smokers, none 
of the associations was increased; and among never-smokers, 
FIGURE 1. Kernel  plot  showing  distributions  of  cumulative 
asbestos exposure in exposed control subjects among women 
and men in the SYNERGY project.
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TABLE 2. Lung Cancer ORs and 95% CIs in Relation to Indices of Occupational Asbestos Exposure in the SYNERGY Study, 
1985–2010
Indices of Occupational  
Asbestos Exposure
Exposure 
Category
Men Women
Cases (%) Controls (%) OR3a (95% CI) Cases (%) Controls (%) OR3a (95% CI)
Occupational asbestos exposure never 6,629 (48.8) 9,608 (58.5) 1.00 (reference) 2,717 (84.9) 3,898 (88.4) 1.00 (reference)
ever 6,958 (51.2) 6,802 (41.5) 1.24 (1.18, 1.31) 482 (15.1) 510 (11.6) 1.12 (0.95, 1.31)
Duration (years) 1–9 2,425 (17.8) 2,603 (15.9) 1.16 (1.07, 1.25) 303 (9.5) 300 (6.8) 1.16 (0.96, 1.42)
10–19 1,375 (10.1) 1,374 (8.4) 1.19 (1.08, 1.30) 102 (3.2) 122 (2.8) 1.08 (0.79, 1.47)
20–29 1,141 (8.4) 1,012 (6.2) 1.34 (1.21, 1.49) 48 (1.5) 57 (1.3) 0.94 (0.61, 1.46)
30+ 2,017 (14.8) 1,813 (11.0) 1.35 (1.25, 1.47) 29 (0.9) 31 (0.7) 1.18 (0.66, 2.11)
  test for trend, P value   <0.01   0.48
  excl. never asbestos exposed   <0.01   0.98
cumulative exposure (ff/ml-years) <0.5 1,206 (8.9) 1,593 (9.7) 1.06 (0.96, 1.16) 194 (6.1) 230 (5.2) 1.11 0.87, 1.42
<1.2 1,624 (12.0) 1,713 (10.4) 1.26 (1.15, 1.37) 104 (3.3) 104 (2.4) 0.95 (0.69, 1.31)
<2.8 1,840 (13.5) 1,724 (10.5) 1.25 (1.15, 1.36) 110 (3.4) 106 (2.4) 1.23 (0.90, 1.68)
>2.8 2,288 (16.8) 1,772 (10.8) 1.38 (1.27, 1.50) 74 (2.3) 70 (1.6) 1.22 (0.84, 1.78)
  test for trend, P value   <0.01   0.17
  excl. never asbestos exposed   <0.01   0.82
time since last exposure (years)b 1–4 1,646 (12.1) 1,589 (9.7) 1.17 (0.99, 1.37) 75 (2.3) 67 (1.5) 1.53 (0.93, 2.53)
5–9 838 (6.2) 765 (4.7) 1.18 (1.00, 1.40) 34 (1.1) 36 (0.8) 1.33 (0.72, 2.47)
10–19 1,297 (9.5) 1,171 (7.1) 1.19 (1.03, 1.37) 79 (2.5) 81 (1.8) 1.27 (0.81, 2.00)
20–29 924 (6.8) 917 (5.6) 1.12 (0.98, 1.27) 85 (2.7) 106 (2.4) 1.10 (0.75, 1.61)
30–39 1,127 (8.3) 1,162 (7.1) 1.16 (1.04, 1.29) 85 (2.7) 106 (2.4) 0.94 (0.65, 1.34)
40+ 1,126 (8.3) 1,198 (7.3) 1.10 (0.99, 1.22) 124 (3.9) 114 (2.6) 1.32 (0.96, 1.80)
  test for trend, P value    0.44   0.44
  excl. never asbestos exposed    0.44   0.44
aOr3 is adjusted for study, age group, smoking (pack-years, time-since-quitting smoking), and list a jobs.
bOr3 in “time since last asbestos exposure” is in addition adjusted for duration (continuous) of asbestos exposure.
FIGURE 2. Exposure–response relationship among men and women for cumulative asbestos exposure with different lag periods 
applied and 95% CIs around the 0-year-lag curve, adjusted for study, age group, cigarette pack-years, time-since-quitting smok-
ing, and ever-employment in a “list A” job. The histograms on the x axis show how the study populations are distributed.
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our results showed no association for lung adenocarcinoma or 
squamous-cell lung cancer but a relatively strong association 
for small-cell lung cancer even at low levels of asbestos expo-
sure (<1.2 ff/ml-years: Or, 3.51; 95% ci, 1.29, 9.55).
Joint Effects of Asbestos and Smoking
table 5 shows the joint effects of asbestos exposure and 
smoking, overall and by lung cancer subtype. in men, the joint 
effect of smoking and asbestos was more than additive for all 
lung cancer subtypes, with a higher excess risk due to interac-
tion for squamous- and small-cell lung carcinoma than for lung 
adenocarcinoma, whereas there was no deviation from a multi-
plicative scale (P = 0.10–0.90). Patterns were similar in women, 
but the reris were not significantly different from 0, except for 
squamous-cell lung carcinoma. the strong association between 
asbestos exposure and small-cell lung carcinoma in never-smok-
ers resulted in a submultiplicative interaction with smoking, in 
women (P = 0.01) but not in men (P = 0.10). a complementary 
table including Ors for models with and without interaction 
between occupational asbestos exposure and smoking is shown 
in etable 6 (http://links.lww.com/eDe/B144).
DISCUSSION
We investigated the quantitative association between 
occupational asbestos exposure and lung cancer risk in the 
SYnergY project by sex, smoking status, and lung cancer 
subtype. increasing duration and increasing cumulative asbes-
tos exposure were associated with an increasing lung cancer 
risk in men. Moreover, the increased lung cancer risk in men 
was observed in never-smokers, former smokers, and current 
smokers, and for all three major lung cancer subtypes. Sensi-
tivity analyses revealed that results were not driven by expo-
sure in any particular industry or study. Women were exposed 
to lower levels of asbestos than men (median, 0.57 vs. 1.21 
ff/ml-years), which may explain the weaker association with 
lung cancer among women. the interaction between asbestos 
exposure and smoking was more than additive for all major 
lung cancer subtypes among men and for squamous-cell lung 
carcinoma among women; moreover, the interaction between 
asbestos and smoking among men did not deviate from mul-
tiplicativity. the results from our pooled analysis of case–
control studies are in broad agreement with those obtained by 
Wraith and Mengersen12 in a meta-analysis of industry-based 
cohort and case–control studies, although our study adds 
results on the interaction between smoking and asbestos by 
lung cancer subtype.
lagged exposure estimates generated very similar 
results (not shown) to those of unlagged estimates; a possible 
explanation is that the relative exposure distribution remained 
the same because most exposed subjects were exposed to no 
or low exposure levels in recent decades, particularly after the 
implementation of asbestos bans in the different countries. 
TABLE 3. Lung Cancer ORs and 95% CIs in Relation to Cumulative Asbestos Exposure in Restricted Strata (Sensitivity Analyses) 
of Men in the SYNERGY Study, 1985–2010
Cumulative Asbestos  
Exposure (ff/ml-years)
Studies with  
Population Controls
Studies with  
Hospital Controls
Restricting the Study  
Base to Blue-collar Workers
ca/co OR3a (95% CI) ca/co OR3a (95% CI) ca/co OR3a (95% CI)
Unexposed 5,136/7,894 1 1,609/1,714 1 4,067/4,721 1
<0.5 1,048/1,447 1.05 (0.95, 1.17) 188/146 1.14 (0.89, 1.47) 1,183/1,552 0.93 (0.84, 1.03)
<1.2 1,376/1,502 1.28 (1.16, 1.40) 267/211 1.26 (1.02, 1.57) 1,588/1,653 1.12 (1.02, 1.23)
<2.8 1,428/1,328 1.31 (1.19, 1.44) 429/396 1.06 (0.90, 1.26) 1,810/1,663 1.11 (1.02, 1.22)
>2.8 1,563/1,161 1.50 (1.35, 1.66) 611/725 1.16 (1.00, 1.34) 2,249/1,724 1.23 (1.12, 1.35)
test for trend, P value  <0.01  0.02  <0.01
excl. never asbestos exposed  <0.01  0.82  <0.01
Cumulative Asbestos  
Exposure (ff/ml-years)
Restricted to Workers  
Started 1960 or Later
Excluding Laborers Not Elsewhere 
Classified (ISCO 9–99.10)   
ca/co OR3a (95% CI) ca/co OR3a (95% CI)   
Unexposed 1,709/2,836 1 6,572/9,544 1   
<0.5 395/570 0.96 (0.80, 1.14) 1,032/1,359 1.06 (0.96, 1.17)   
<1.2 411/463 1.19 (1.00, 1.42) 1,318/1,443 1.23 (1.12, 1.35)   
<2.8 405/395 1.40 (1.17, 1.67) 1,461/1,372 1.28 (1.16, 1.40)   
>2.8 279/267 1.27 (1.02, 1.59) 1,752/1,442 1.33 (1.21, 1.46)   
test for trend, P value  <0.01  <0.01   
excl. never asbestos exposed  0.06  <0.01   
aOr3 is adjusted for study, age group, smoking (pack-years, time-since-quitting smoking), and list a jobs.
ca indicates cases; co, controls.
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also, many workers had been retired for many years when 
they were diagnosed with lung cancer, and therefore their 
exposure did not change much, even when lagged.
the quality of the exposure assessment has a strong 
influence on the estimation of the exposure–response associa-
tion.23 So far, quantitative estimates based on measurements 
TABLE 4. Lung Cancer ORs and 95% CIs in Relation to Cumulative Asbestos Exposure Stratified by Lung Cancer Cell Type and 
Smoking Status Among Men and Women in the SYNERGY Study, 1985–2010
Lung Cancer  
Cell Type
Asbestos  
Exp.  
(ff/ml-years)
Never-smokersa Former Smokersb Current Smokersc
Control Case OR (95% CI) Control Case OR (95% CI) Control Case OR (95% CI)
Men
  all lung cancer Unexposed 2,875 283 1 4,185 2,363 1 2,548 3,983 1
<1.2 801 103 1.31 (1.02, 1.69) 1,526 1,001 1.20 (1.08, 1.33) 979 1,726 1.12 (1.01, 1.24)
>1.2 745 102 1.51 (1.16, 1.97) 1,609 1,421 1.38 (1.25, 1.52) 1,142 2,605 1.21 (1.10, 1.34)
   test for trend, P value   <0.01   <0.01   <0.01
   excl. never asbestos exposed   0.04   <0.01   0.06
  adenocarcinoma Unexposed 2,875 103 1 4,185 663 1 2,548 976 1
<1.2 801 34 1.13 (0.75, 1.72) 1,526 268 1.10 (0.93, 1.30) 979 425 1.05 (0.90, 1.22)
>1.2 745 40 1.52 (1.00, 2.29) 1,609 340 1.30 (1.11, 1.53) 1,142 470 1.06 (0.92, 1.23)
   test for trend, P value   0.07   <0.01   0.23
   excl. never asbestos exposed   <0.01   <0.01   <0.01
  Squamous cell Unexposed 2,875 78 1 4,185 984 1 2,548 1,617 1
<1.2 801 36 1.72 (1.13, 2.61) 1,526 441 1.32 (1.14, 1.52) 979 707 1.18 (1.04, 1.34)
>1.2 745 27 1.27 (0.78, 2.06) 1,609 670 1.47 (1.29, 1.67) 1,142 1,264 1.29 (1.16, 1.45)
   test for trend, P value   0.04   <0.01   <0.01
   excl. never asbestos exposed   <0.01   <0.01   <0.01
  Small cell Unexposed 2,875 26 1 4,185 312 1 2,548 729 1
<1.2 801 12 1.55 (0.76, 3.18) 1,526 123 1.12 (0.89, 1.42) 979 297 1.05 (0.89, 1.24)
>1.2 745 18 2.73 (1.39, 5.35) 1,609 192 1.36 (1.10, 1.68) 1,142 487 1.22 (1.05, 1.43)
   test for trend, P value   <0.01   <0.01   0.02
   excl. never asbestos exposed   <0.01   <0.01   <0.01
Women
  all lung cancer Unexposed 2,377 755 1 749 557 1 772 1,405 1
<1.2 139 42 1.06 (0.72, 1.54) 101 49 0.71 (0.46, 1.08) 94 207 1.22 (0.90, 1.66)
>1.2 128 59 0.95 (0.67, 1.34) 25 26 1.09 (0.57, 2.07) 23 99 2.05 (1.24, 3.40)
   test for trend, P value   0.95   0.18   <0.01
   excl. never asbestos exposed   0.96   0.32   0.16
  adenocarcinoma Unexposed 2,377 458 1 749 249 1 772 502 1
<1.2 139 22 0.92 (0.57, 1.50) 101 15 0.43 (0.23, 0.79) 94 70 1.11 (0.76, 1.63)
>1.2 128 29 0.73 (0.47, 1.15) 25 13 1.64 (0.74, 3.66) 23 29 2.08 (1.12, 3.88)
   test for trend, P value   0.19   0.14   0.08
   excl. never asbestos exposed   <0.01   <0.01   <0.01
  Squamous cell Unexposed 2,377 99 1 749 129 1 772 306 1
<1.2 139 5 0.92 (0.36, 2.38) 101 18 1.04 (0.53, 2.04) 94 49 1.33 (0.86, 2.07)
>1.2 128 8 0.77 (0.34, 1.73) 25 6 0.77 (0.26, 2.26) 23 31 2.20 (1.15, 4.21)
   test for trend, P value   0.56   0.63   <0.01
   excl. never asbestos exposed   <0.01   <0.01   <0.01
  Small cell Unexposed 2,377 39 1 749 72 1 772 313 1
<1.2 139 5 3.51 (1.29, 9.55) 101 5 0.53 (0.18, 1.55) 94 42 1.15 (0.73, 1.83)
>1.2 128 11 3.71 (1.75, 7.86) 25 2 0.30 (0.04, 2.07) 23 29 2.15 (1.12, 4.12)
   test for trend, P value   <0.01   0.05   0.03
   excl. never asbestos exposed   <0.01   <0.01   <0.01
aOr in never-smokers adjusted for study, age group, and list a jobs.
bOr in former smokers adjusted for study, age group, list a jobs, cigarette pack-years, and time-since-quitting smoking.
cOr in current smokers adjusted for study, age group, list a jobs, and cigarette pack-years.
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have been obtained mainly from industrial cohort studies.24 
We assessed asbestos exposure applying SYn-JeM for gen-
eral population studies, a newly created job-exposure matrix 
based on quantitative workplace measurements from europe 
and canada.
Strengths of this study include the large study popula-
tion, a large proportion of face-to-face interviews conducted 
by trained interviewers, a large proportion of control sub-
jects recruited from the general population, a comprehen-
sive adjustment for smoking, and an innovative and objective 
method, supported by actual measurements, for assess-
ing asbestos exposure quantitatively in general population 
studies.
limitations of the study are that asbestos fiber type and 
dimensions could not be taken into account, because almost 
all measurements (>95%) were determined by phase-contrast 
microscopy, which does not allow the fiber type to be distin-
guished or to identify fibers with width <0.25 μm. For lung 
cancer, scientific uncertainty remains on how much risks dif-
fer in magnitude by fiber type, but recent evidence suggests it 
is less than previously assumed.24,25
Misclassification of exposure is assumed to have 
occurred, but it can also be assumed to be nondifferential pro-
vided reporting of job titles did not differ systematically in 
cases and controls. Differential reporting of job titles is not 
likely; therefore, the use of a job-exposure matrix for exposure 
assessment is unlikely to have created spurious associations.
Further limitations include that measurements were not 
done for individual study subjects, resulting in assignments of 
average exposure levels to job titles and not to individuals, and 
leading to assignment of the same exposure level to all work-
ers sharing the same job code in a particular year, irrespective 
of exposure variability between workers in the same job. this 
results in a Berkson-type error, which usually does not bias 
the point estimate but increases the variance and therefore 
leads to reduced precision.26
Some jobs or unspecific job codes may substantially 
influence the prevalence of exposure if used extensively in a 
study. For example, many jobs were coded as “laborers not 
elsewhere classified” (iScO 9–99.10); in SYn-JeM, this job 
was assigned low exposure to asbestos. the use of the iScO 
9–99.10 job code does not necessarily reflect poor quality of 
interviews or coding, as it could also signify a high prevalence 
of low specialization of laborers and/or low technology in cer-
tain industries. indeed, the asbestos prevalence decreased by 
>10% in some studies when excluding “laborers not elsewhere 
classified.” nevertheless, excluding “laborers not elsewhere 
classified” from the risk analyses did not change the overall 
results, possibly because 9–99.10 jobs represented only 1.8% 
of the total working time.
another limitation is that half of the 36,000 personal 
measurements collected were available for the production of 
asbestos cement and asbestos textiles, job titles that were rare 
in our study population or too specific to be captured by the 
iScO code.15 in the SYnergY study population, only 46 
subjects (32 cases, 14 controls) had ever worked as asbestos 
cement product makers. the number of available data points 
for the remaining, more prevalent jobs was more limited.
TABLE 5. Lung Cancer ORs and 95% CIs, P Value for Multiplicative Interaction and RERI and 95% CI in Relation to 
Occupational Asbestos Exposure and Smoking Among Men and Women Overall and by Major Lung Cancer Cell Types, in the 
SYNERGY Study, 1985–2010
Exposure Status
 
Controls
All Lung  
Cancer Types
Lung  
Adenocarcinoma
Squamous-cell 
Carcinoma
Small-cell  
Carcinoma
Cases ORa (95% CIb) Cases ORa (95% CIb) Cases ORa (95% CIb) Cases ORa (95% CIb)
Men
  never-smoker and never asbestos 2,875 283 1 (reference) 103 1 (reference) 78 1 (reference) 26 1 (reference)
  never-smoker and asbestos 1,546 205 1.26 (1.04, 1.53) 74 1.29 (0.95, 1.75) 63 1.35 (0.96, 1.90) 30 1.97 (1.16, 3.35)
  ever smoker and never asbestos 6,733 6,346 9.23 (8.13, 10.5) 1,639 6.71 (5.47, 8.24) 2,601 13.2 (10.5, 16.7) 1,041 16.8 (11.3, 24.9)
  ever smoker and asbestos 5,256 6,753 11.9 (10.5, 13.6) 1,503 7.91 (6.42, 9.74) 3,082 18.3 (14.5, 23.0) 1,099 21.1 (14.3, 31.3)
  P value multiplicative interaction   0.82  0.59  0.90  0.10
  reric with linear model   2.44 (1.89, 3.08)  0.92 (0.16, 1.59)  4.75 (3.57, 6.55)  3.18 (1.29, 5.92)
Women
  never-smoker and never asbestos 2,377 755 1 (reference) 458 1 (reference) 99 1 (reference) 39 1 (reference)
  never-smoker and asbestos 267 101 1.00 (0.78, 1.29) 51 0.84 (0.60, 1.16) 13 0.92 (0.50, 1.70) 16 3.40 (1.85, 6.26)
  ever smoker and never asbestos 1,521 1,962 4.57 (4.08, 5.12) 751 2.72 (2.36, 3.13) 435 8.90 (7.00, 11.3) 385 17.1 (12.1, 24.1)
  ever smoker and asbestos 243 381 6.26 (5.14, 7.62) 127 3.31 (2.57, 4.28) 104 13.3 (9.49, 18.5) 78 24.3 (15.8, 37.4)
  P value multiplicative interaction   0.05  0.07  0.16  0.01
  reric with linear model   1.69 (0.64, 3.11)  0.76 (−0.11, 1.68)  4.44 (1.02, 9.16)  4.85 (−2.23, 14.21)
aOr adjusted for study, age group, and “list a” jobs.
bcis are based on 1,000 bootstrap samples.
creri indicates relative excess risk due to interaction.
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exposure assessment according to SYn-JeM resulted in 
high prevalence of ever occupational asbestos exposure com-
pared with the original studies.27–30 However, the prevalence 
of asbestos exposure decreased substantially, from 41.3% to 
6.4% among male controls and from 11.3% to 0.3% among 
female controls, when only the DOM-JeM high-exposure 
jobs were considered, which confirms that the vast majority 
of exposed workers were employed in jobs with low average 
exposure levels.
about 60% of all blue-collar workers were rated as ever-
exposed to asbestos. this implies that they may have been 
exposed to many other agents at their workplaces. although 
we controlled for occupations with known exposure to pul-
monary carcinogens, there may still remain some uncertainty 
about residual confounding by other occupational hazards. 
notably, the association between asbestos exposure and 
lung cancer risk was weaker when restricting to blue-collar 
workers. this may be due to a reduction in exposure con-
trast. alternatively, the background lung cancer risk may be 
higher in blue-collar workers than in white-collar workers due 
to other agents in the workplace and various socioeconomic 
factors.31–33 also, selection bias has to be taken into account 
due to a lower participation rate of blue-collar workers among 
population controls.34 the hospital-based studies showed 
lower Ors for asbestos exposure than the population-based 
studies, which may be explained by a combination of factors, 
including choice of control diseases, geographical location 
(possibly reflecting different exposure patterns), study size, or 
other factors.
levels of occupational asbestos exposure in this pooled 
analysis of general population studies were lower (range, 
0.0023–64.6 ff/ml-years in male controls) than in the 18 indus-
trial cohort studies (range, 0.11–4,710 ff/ml-years) included in 
a recent review of exposure–response relationships.24 a prob-
able reason for the rather low levels of occupational asbestos 
exposure seen in SYnergY is that major “asbestos occupa-
tions” such as asbestos cement product makers and asbestos 
textile workers are rare in a general population study setting. 
instead, exposures in SYnergY represent a wider exposure 
range, with very few workers exposed to high levels and most 
being downstream users or indirectly exposed workers occa-
sionally exposed or exposed to lower concentrations of fibers 
only.
Our large dataset may be particularly informative to 
explore the shape of the exposure–response function in the 
low-dose range. an additional advantage was stratification or 
detailed adjustment for smoking. in our analysis of pooled 
general population studies, the exposure–response slope esti-
mated as excess risk per 100 fiber-years (KL * 100) was 6.1 
(95% ci, 4.1, 8.1) in men overall and 3.3 (95% ci, 1.5, 5.0) 
among male blue-collar workers. the KL * 100 slope was flat 
in a recent meta-analysis of 18 occupational cohort studies 
(KL * 100, 0.13; 95% ci, 0.04, 0.22), while it was rather steep 
(KL * 100, 15.5; 95% ci, 1.13, 29.87) in lUcaS, the general 
population study from Stockholm, which also is part of SYn-
ergY.24,35 the SYnergY KL * 100 estimate in blue-collar 
workers (3.3; 95% ci, 1.5, 5.0) is still considerably higher 
than the estimate from the industrial cohorts in lenters’ paper, 
which were considered to have good-quality exposure assess-
ment (e.g., seven cohort studies with >30% coverage of expo-
sure data; KL * 100, 0.27; 95% ci, 0.08, 0.46). a possible 
reason for the steeper slope we observed in general population 
studies is that we could assess the full occupational history, 
resulting in a more distinct exposure contrast, and that we 
could identify a substantial proportion of truly nonexposed. 
However, there is little evidence in the literature regarding the 
shape of the exposure–response curve at low levels of expo-
sure.25,36 Our dataset is less informative regarding the high-
dose range; only 90 of 29,997 male participants were assessed 
as exposed to ≥15 fiber-years. the exposure–response results 
presented here are based on exposure–response modeling 
agreed upon a priori. this model assumes ln(Or) is propor-
tional to ln(exposure). Other exposure–response models will 
result in different risk estimates.
We observed a stronger association between asbes-
tos exposure and small-cell lung carcinoma among never-
smokers in both men and women. this is noteworthy because 
small- and squamous-cell lung carcinomas occur almost 
exclusively in cigarette smokers; in SYnergY, only 4% 
of small- and squamous-cell cases were never-smokers, 
whereas 14% of lung adenocarcinoma cases were never-
smokers. However, we cannot rule out biased recall of smok-
ing habits.37
Some misclassification of the histological subtypes of 
lung cancer is likely; one of the studies (Hda) included in 
SYnergY assessed diagnostic agreement between patholo-
gists and found a kappa of 0.54 (95% ci, 0.49, 0.58).14 Small-
cell lung cancer was best classified, followed by squamous-cell 
lung cancer and lung adenocarcinoma. Most misclassification 
was between squamous-cell lung cancer and lung adenocar-
cinoma. thus, our results for the major lung cancer subtypes 
should be interpreted with caution.
Our results show an excess risk of lung cancer and its 
subtypes at relatively low levels of cumulative exposure (>0.5 
ff/ml-years), which persisted at least up to 40 years after last 
exposure. Furthermore, the slope of the exposure–response 
relationship seemed steeper in this exposure range than at 
higher (and previously studied) levels. together, this implies 
that the future burden of disease due to asbestos exposure may 
be underestimated.
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